Overview

Also Known As:B6-staggerer

The cerebellar cortex of homozygous mutant staggerer (Rora^sg) mice show a deficiency of granule cells and Purkinje cells. They have a staggering gait, mild tremor, and hypotonia. These mice may be useful in studies of the composition and function of granule cells.

Genetic overview

Genetic Background	Generation
000664 C57BL/6J

Rora^sg

Allele Type	Gene Symbol	Gene Name
Spontaneous	Rora	RAR-related orphan receptor alpha

View Genetics

Research Applications

Neurobiology Research

View All Research Applications

Base Price

Starting at:

$2,854.50 Domestic price Cryo Recovery

View Price List

Details

Detailed Description

Mice homozygous for the staggerer spontaneous mutation (Rora^sg) show a staggering gait, mild tremor, hypotonia, and small size. The cerebellar cortex of homozygous mutant mice is grossly underdeveloped with a deficiency of granule cells and Purkinje cells. The remaining granule cells migrate inward from the external layer prematurely and then degenerate. Purkinje cells are much delayed in postnatal differentiation and lack the dendritic spines on which synapses with the parallel fibers from the granule cells normally occur. Staggerer mutant mice have been used as a source of an agranulate cerebellum in a number of investigations of the composition and function of granule cells. Kopmels et al. have reported a hyperproduction of IL1 biological activity and mRNA from LPS stimulated spleen cells of Rora^sg/Rora^sg mice on the C57BL/6J background relative to wild type siblings. In addition, homozygous mice exhibit an enhanced susceptibility to LPS-induced lung inflammation, suggesting a role for Rora in LPS-induced inflammatory responses (Stapleton CM, et al., 2005).

Development

The first Rora^sg/Rora^sg mouse was observed in 1955 among the F2 progeny of a (BALB/cHm x C3H/HeJ)F1 female and a male of an obese(Lep^ob) stock of mixed background. The mutation was maintained for several generations by an intercross-backcross (within the same or a parallel lineage) mating scheme, then was backcrossed onto C57BL/6J for four generations. A Rora^sg/+ male from the fourth backcross was mated to a female C57BL/10-Myo5a^d Bmp5^se mouse to introduce the dilute and short-ear mutations into the stock in repulsion with Rora^{6 sg} ; this allowed the heterozygotes (Rora^sg + +/+ Myo5a^d Bmp5^se to be identified by a lack of either recessive phenotype. Brother-sister inbreeding was continued. At F55, Myo5a^d Bmp^se was backcrossed onto C57BL/6J seven times; at F58, Rora^sg was backcrossed onto C57BL/6J four times. The Rora^sg + +/+ Myo5a^d Bmp5^se stock was then reconstructed by crossing mice of the two independent stocks and maintained by brother-sister inbreeding. In early 1997, Myo5a^d and Bmp5^se were bred out of the stock by selective breeding assisted by PCR testing. Based on the alleles carried by this strain for 16 SSLPs mapping within 1 cM of Rora, it appears that the mutation occurred on a C3H chromosome (Hamilton et al. 1996).

Control Suggestions

Wild type mice from the colony are the preferred controls. Untyped mice from the colony may be used; however, heterozygotes exhibit "accelerated loss of Purkinje cells, granule cells, and inferior olivary neurons with age" (MLC; Zanjani et al.1992; Hadj-Sahraoui et al.1997).
Wild-type from the colony

Additional Information

Considerations for Choosing Controls

Selected References

Mamontova A; Seguret-Mace S; Esposito B; Chaniale C; Bouly M; Delhaye-Bouchaud N; Luc G; Staels B; Duverger N; Mariani J; Tedgui A. 1998. Severe atherosclerosis and hypoalphalipoproteinemia in the staggerer mouse, a mutant of the nuclear receptor RORalpha. Circulation 98(24):2738-43PubMed: 9851961 MGI: J:52105
SIDMAN RL; LANE PW; DICKIE MM. 1962. Staggerer, a new mutation in the mouse affecting the cerebellum. Science 137:610-2PubMed: 13912552 MGI: J:13140

View All References

Genetics

Rora^sg

Allele Symbol: Rora^sg

Allele Name	staggerer
Allele Type	Spontaneous
Allele Synonym(s)	RORalpha^-; sg
Gene Symbol and Name	Rora, RAR-related orphan receptor alpha
Gene Synonym(s)
Strain of Origin	obese stock
Chromosome	9
Molecular Note	This allele contains a 6.5kb genomic deletion of an exon encoding part of the ligand binding domain. The deletion results in an exon-skipping event that introduces a shift in the reading frame. The resulting protein is predicted to be truncated due to introduction of a premature stop codon.

Disease/Phenotype

Disease Terms

Research Areas By Phenotype

This mouse can be used to support research in many areas including:

Genotype: Rora^sg related

Neurobiology Research
- Ataxia (Movement) Defects
- Receptor Defects
- Tremor Defects
- Cerebellar Defects
  - Purkinje cell defect

Mammalian Phenotype Terms by Genotype

The following phenotype information is associated with a similar, but not exact match to this JAX^® Mice strain

Genotype: Rora^sg/Rora^sg
involves: obese stock

behavior/neurological phenotype

abnormal gait
- abnormal gait is apparent at ~2 weeks of age
- gait is shuffling and hesitant, interrupted every few steps by lurching motions side-to-side

abnormal limb posture
- some animals have hindlimbs held abducted and everted at 45 degrees at rest

abnormal motor capabilities/coordination/movement

abnormal motor learning
- mice hang onto the rod as opposed the walking strategy WT mice exclusively use
- mice have an impaired ability to learn how to hang onto a rotating rod
- scores do not improve with 10 days of training

ataxia
- treatment with a thyrotropin releasing hormone analog improves ataxia (fewer falls in a given distance travelled)

decreased grip strength
- mice have a mean hanging time of 12 seconds compared to over 3 minutes for WT mice

hypoactivity
- mutants remain stationary much more than littermates

impaired coordination
- mice fall off an elevated rod on average of 13 seconds compared to over 3 minutes for WT mice
- mice fall off an elevated rod on average of 13 seconds compared to over 3 minutes for WT mice

limb grasping
- is observed in all mice

tremors
- mild tremors accompany initiation of movement

growth/size/body region phenotype

decreased body size
- mutants are smaller than littermates

homeostasis/metabolism phenotype

abnormal hormone level
- prothyrotropin releasing hormone levels are elevated in the thalamus, cerebellum, brainstem, and spinal cord

mortality/aging

postnatal lethality, incomplete penetrance
- about 50% of mutants die by weaning

nervous system phenotype

abnormal brain morphology

abnormal cerebellar foliation

abnormal cerebellar granule cell morphology
- cells migrate prematurely from the external granule layer having undergone fewer cell divisions
- conspicuous differences in the internal granule layer at 10 days of age
- external granule layer less developed at birth
- reduced rate of cell proliferation at 1 and 5 days of age

abnormal cerebellar granule layer morphology
- granular cell layer displays a paucity of cells in mutants

abnormal cerebellar layer morphology

abnormal cerebellar molecular layer

abnormal cerebellum morphology
- adult cerebellar cell surface with embryonic characteristics
- cells agglutinable with wheat germ agglutinin but not wit h Con-A
- cerebellum is less than one-third the size of wild-type littermates
- cerebellum of adults shows tiny folia with indistinct fissures

abnormal cochlear VIII nucleus morphology
- cartwheel cells are rarely seen in adults
- cochlear nuclei are reduced in volume and severely malformed
- dendritic spines are rare on cartwheel cells at 1 month of age

abnormal nervous system physiology
- immunoreactive somatostatin is significantly elevated in both the cerebrum and in the cerebellum

abnormal olfactory bulb external plexiform layer morphology
- large, empty, intercellular spaces
- lower density of secondary dendrites
- thinner than controls

abnormal olfactory bulb glomerular layer morphology
- glomerular surface reduced about 15%
- reduced cell number and intercellular space
- reduced number of interneuronal relays
- thinner than controls

abnormal olfactory bulb granule cell layer morphology
- composed of several layers of anaxonal interneurons with smaller than normal cell bodies
- nuclear size is smaller than controls

abnormal olfactory bulb granule cell morphology
- pycnotic nuclei
- vacuolations and ruptured membranes

abnormal olfactory bulb internal plexiform layer morphology
- less distinct
- thinner than controls

abnormal olfactory bulb layer morphology

abnormal olfactory bulb mitral cell layer morphology
- somewhat discontinuous

abnormal olfactory bulb morphology
- dendro-dendritic asymmetrical synapses are abundant
- fewer astrocytes found

abnormal olfactory bulb outer nerve layer morphology
- glial cells with more processes ensheathing axons in the nerve layer

abnormal Purkinje cell morphology
- cells are randomly oriented
- poorly elaborated dendritic trees

decreased cerebellar granule cell number
- 25% reduction in granule cells in the internal granule cell layer

small cerebellum
- less than half of control weight at 5 days of age
- weight is significantly less than controls even before neurological symptoms appear

small olfactory bulb
- volume slightly reduced

thin cerebellar molecular layer

Genotype: Rora^sg/Rora^sg
involves: C57BL/6

behavior/neurological phenotype

abnormal maternal nurturing
- females from heterozygous parents fail to nurture pups to weaning
- females from selected homozygous lineages sometimes (9/14) raise pups to weaning although growth rate of pups is lower than normal

abnormal sexual interaction
- one to two months of social isolation results in increased mounting behavior when a receptive female is encountered
- successful mating occurs from 35-160 days after the end of male isolation
- vestibular stimulation improves the ability of males to mate with experienced females

abnormal spatial learning
- higher latency to escape at all time tested using two types of water maze
- less age related degradation in latency to escape although it is always greater than in controls

endocrine/exocrine gland phenotype

thymus atrophy

hematopoietic system phenotype

abnormal macrophage physiology
- LPS stimulated macrophage produce 2 fold more IL-1 relative to macrophage of controls

increased IgE level
- levels are elevated in unsensitized mice
- OVA challenge of sensitized mice causes a very great increase in IgE levels
- OVA sensitization causes an additional elevation in IgE levels

spleen atrophy

thymus atrophy

homeostasis/metabolism phenotype

abnormal lipid homeostasis
- plasma APOA1 and APOA2 concentrations are approximately 2 fold lower than in wild-type controls on a normal diet, and the Apoa1 mRNA level in intestine is diminished relative to wild-type, although liver expression of Apoa1 is comparable with wild-type
- the production rate of APOA1 is diminished, but the fractional catabolic rate is comparable to wild-type

decreased circulating cholesterol level
- although cholesterol levels increase on an atherosclerotic diet, homozygotes still have lower plasma cholesterol than wild-type controls also fed this diet
- plasma total cholesterol levels are significantly lower in both male and female homozygotes than in wild-type controls

decreased circulating HDL cholesterol level
- plasma HDL cholesterol level is significantly lower in both male and female homozygotes than in wild-type controls, and females have significantly lower plasma HDL level than males both for the homozygous and wild-type data sets. This is true even on an atherogenic diet.
- therogenic diet.

immune system phenotype

abnormal immune system organ morphology

abnormal immune system physiology
- abnormal immune responses

abnormal macrophage physiology
- LPS stimulated macrophage produce 2 fold more IL-1 relative to macrophage of controls

increased IgE level
- levels are elevated in unsensitized mice
- OVA challenge of sensitized mice causes a very great increase in IgE levels
- OVA sensitization causes an additional elevation in IgE levels

increased interleukin-1 secretion
- LPS stimulated macrophage produce 2 fold more IL-1 relative to macrophage of controls

lung inflammation
- less alveolar infiltration as well
- less increase of IL-4, IL-5, and IL-13
- less increase of inflammatory cells in bronchoalveolar lavage
- OVA sensitized and challenged mice experience less infiltration of lymphocytes and polymorphonuclear cells into peribronchiolar and perivascular regions of the lungs

spleen atrophy

thymus atrophy

mammalian phenotype

immune system phenotype
- white blood cell, lymphocyte, and neutrophil counts are not significantly different between homozygotes and wild-type controls

taste/olfaction phenotype
- Normal - male mice are able to distinguish between the vaginal secretions of estrus and non-estrus females

muscle phenotype

abnormal vasoconstriction
- contractions of the mesenteric artery induced by phenylephrin or serotonin are less than in controls

abnormal vasodilation
- blood flow induced dilation of the mesenteric artery is less than for controls
- endothelium-dependent and independent dilation is reduced

nervous system phenotype

abnormal cerebellum morphology
- embryonic, high sialic acid forms of N-CAM persist on cell surfaces to 14 and 21 days of age

abnormal inferior olivary complex morphology
- adult cell bodies are smaller than in newborns
- decreased cell density
- definition of subnuclei is better in 21 day old mice but regresses in adults
- individual olivary subnuclei are poorly defined relative to controls
- inferior olive extends further dorsally in the midline
- number of neurons drops 30% within 3 days of birth and continues to decline for 2 months
- number of neurons in adults is decreased 60% relative to newborns
- olivary dendrites tend to be multipolar and well branched

reproductive system phenotype

abnormal estrous cycle
- irregular cycles

abnormal external female genitalia morphology
- vaginal opening averaged 35 days (never earlier than 31 days) while controls averaged 28 days (earliest 26 days)

abnormal female reproductive system physiology

abnormal fertility/fecundity
- no unstimulated couples mated
- some couples receiving vestibular stimulation mated between the ages of 36 and 89 days of age

delayed estrous cycle
- onset of estrus at 45 days vs 40 days for controls

prolonged estrus
- prolonged vaginal estrus relative to controls

prolonged metestrus

reduced female fertility
- females sexual activity decreases after 4.5 months
- no females mate before 2.5 months of age
- only one of 10 females still mating at 6 months of age

respiratory system phenotype

abnormal lung compliance
- lung resistance in response to methacholine challenge of OVA exposed mice fails to increase

abnormal respiratory mucosa morphology
- less mucous cell hyperplasia in airways after OVA exposure of sensitized mice

lung inflammation
- less alveolar infiltration as well
- less increase of IL-4, IL-5, and IL-13
- less increase of inflammatory cells in bronchoalveolar lavage
- OVA sensitized and challenged mice experience less infiltration of lymphocytes and polymorphonuclear cells into peribronchiolar and perivascular regions of the lungs

taste/olfaction phenotype

abnormal olfaction
- amyl alchohol odor induced evoked field potential shows an increased latency preceding the functional response of mitral cells in the olfactory bulb
- attractive threshold concentration for vanillin is increased
- aversive threshold concentration for butanol is increased
- N1 and N2 response amplitudes of the evoked field potential are significantly reduced

cardiovascular system phenotype

abnormal vasoconstriction
- contractions of the mesenteric artery induced by phenylephrin or serotonin are less than in controls

abnormal vasodilation
- blood flow induced dilation of the mesenteric artery is less than for controls
- endothelium-dependent and independent dilation is reduced

atherosclerotic lesions
- the atherosclerotic lesions induced in homozygotes by 9 weeks of an atherosclerotic diet have a 6 fold greater area in female homozygotes and a 7.5 fold greater area in male homozygotes than those in wild-type controls on the same diet

decreased mean systemic arterial blood pressure
- 80mmHg vs 87mmHg for controls
- acetyl choline causes less blood pressure decrease than in controls
- phenylephrine causes less blood pressure increase than in controls

increased angiogenesis
- 3 fold increase in capillary density relative to controls
- 80% rise in vascular density relative to controls
- significantly increased in the ischemic leg 28 days after femoral artery ligature

increased susceptibility to atherosclerosis
- Although homozygotes fed a normal diet do not display abnormal atherosclerotic lesions, 9 weeks of an atherosclerotic diet induces exaggerated altherosclerotic lesions compared with wild-type controls on the atherosclerotic diet

Genotype: Rora^sg/Rora^sg
involves: C57BL

cellular phenotype

abnormal Purkinje cell differentiation
- retarded

homeostasis/metabolism phenotype

decreased aspartic acid level
- aspartate levels decline between 7 and 10 days; low levels persist

decreased gamma-aminobutyric acid level
- GABA levels are 52% of controls at 7 days and 30% at 3 weeks
- GABA levels in deep cerebellar nuclei are reduced at all ages examined

decreased taurine level
- taurine levels decline between 7 and 10 days; low levels persist

increased noradrenaline level
- measurably increased in the spinal cord
- significantly elevated in cerebellum
- significantly elevated in cerebral cortex

nervous system phenotype

abnormal cerebellar granule cell morphology
- degenerating parallel fibers begin to appear around 7 days and is well advanced by 14 days
- no synapses form between the parallel fibers and the Purkinje cell spines at 14 to 43 days of age
- synapses do develop between parallel fibers and stellate and basket cells

abnormal cerebellar granule layer morphology

abnormal cerebellar layer morphology

abnormal cerebellar Purkinje cell layer
- Purkinje cell band thicker at 3 days of age

abnormal cerebellum deep nucleus morphology
- area occupied by deep neurons is reduced to 36% of controls but cell numbers are not reduced
- neurons in the deep nuclei are smaller than seen in controls
- white matter in deep cerebellar nuclei is reduced to 42% of controls

abnormal cerebellum morphology
- cell surface antigen characteristics more embryonic in nature

abnormal Purkinje cell dendrite morphology
- no synapses form between Purkinje cell spines and the parallel fibers at 14 to 43 days of age
- reduced growth of dendrite arbor

abnormal Purkinje cell differentiation
- retarded

abnormal Purkinje cell morphology
- 60-90% of Purkinje cells are lost
- cells smaller in size with thinner processes
- larger, typical Purkinje cells are absent in intermediate regions of the cerebellum
- multiple climbing fiber synaptic connections to each Purkinje cell are maintained

abnormal synaptic glutamate release
- glutamate levels drop between 7 and 10 days
- levels continue to drop over time

decreased aspartic acid level
- aspartate levels decline between 7 and 10 days; low levels persist

decreased gamma-aminobutyric acid level
- GABA levels are 52% of controls at 7 days and 30% at 3 weeks
- GABA levels in deep cerebellar nuclei are reduced at all ages examined

delaminated Purkinje cell layer
- typical laminar array fails to form

increased noradrenaline level
- measurably increased in the spinal cord
- significantly elevated in cerebellum
- significantly elevated in cerebral cortex

small cerebellum
- 62% of normal weight at birth
- weight is 36% of normal at 7 days

thin cerebellar granule layer

thin cerebellar molecular layer

Genotype: Rora^sg/Rora⁺
involves: C57BL

nervous system phenotype

abnormal cerebellar granule layer morphology
- cell density is reduced
- granule cell layer decreases with age

abnormal cerebellar layer morphology

abnormal cerebellum morphology

abnormal inferior olivary complex morphology
- neuron counts are 60% of controls at 1 year of age

decreased cerebellar granule cell number
- cell numbers are about 35% of controls

decreased Purkinje cell number
- significant loss of Purkinje cells at 1 year of age

small cerebellum
- decreased cross-sectional area of the cerebellum at 1 year of age

The following phenotype relates to a compound genotype created using this strain

Genotype: Rora^sg/Rora⁺
involves: C57BL/6J

behavior/neurological phenotype

abnormal spatial learning
- mice exhibit impaired spatial learning in a Z-maze filled with water compared with wild-type mice

References

Mamontova A; Seguret-Mace S; Esposito B; Chaniale C; Bouly M; Delhaye-Bouchaud N; Luc G; Staels B; Duverger N; Mariani J; Tedgui A. 1998. Severe atherosclerosis and hypoalphalipoproteinemia in the staggerer mouse, a mutant of the nuclear receptor RORalpha. Circulation 98(24):2738-43PubMed: 9851961 MGI: J:52105
SIDMAN RL; LANE PW; DICKIE MM. 1962. Staggerer, a new mutation in the mouse affecting the cerebellum. Science 137:610-2PubMed: 13912552 MGI: J:13140

Additional References

Hamilton BA; Frankel WN; Kerrebrock AW; Hawkins TL; FitzHugh W; Kusumi K; Russell LB; Mueller KL; van Berkel V; Birren BW; Kruglyak L; Lander ES. 1996. Disruption of the nuclear hormone receptor RORalpha in staggerer mice. Nature 379(6567):736-9PubMed: 8602221 MGI: J:31470
Heuze P; Feron C; Baudoin C. 1997. Early behavioral development of mice is affected by staggerer mutation as soon as postnatal day three. Brain Res Dev Brain Res 101(1-2):81-4PubMed: 9263582 MGI: J:42144
Kopmels B; Wollman EE; Guastavino JM; Delhaye-Bouchaud N; Fradelizi D; Mariani J. 1990. Interleukin-1 hyperproduction by in vitro activated peripheral macrophages from cerebellar mutant mice. J Neurochem 55(6):1980-5PubMed: 2230805 MGI: J:28095
Perandones C; Costanzo RV; Kowaljow V; Pivetta OH; Carminatti H; Radrizzani M. 2004. Correlation between synaptogenesis and the PTEN phosphatase expression in dendrites during postnatal brain development. Brain Res Mol Brain Res 128(1):8-19PubMed: 15337313 MGI: J:92848
Yoon CH. 1972. Developmental mechanism for changes in cerebellum of staggerer mouse, a neurological mutant of genetic origin. Neurology 22(7):743-54PubMed: 4673255 MGI: J:5304
Zanjani HS; Mariani J; Delhaye-Bouchaud N; Herrup K. 1992. Neuronal cell loss in heterozygous staggerer mutant mice: a model for genetic contributions to the aging process. Brain Res Dev Brain Res 67(2):153-60PubMed: 1511513 MGI: J:1431

Additional - Rora^sg related

Technical Support

CONTACT TECHNICAL SUPPORT

Genotyping Protocols
- Standard PCR:Rora
- Standard PCR:Rora
- Genotyping resources and troubleshooting
Breeding Considerations

Rora^sg/Rora^sgmice can be identified by 10-15 days of age by their poor locomotor coordination, lurching movements and frequent falls; homozygotes as young as three days can be distinguished by behavioral testing (Heuze et al.1997). Homozygotes die between two to three weeks of age. Due to their early and high mortality, homozygous mutant mice are not available from our colony. In some cases, the homozygote lifespan can be extended by adding crushed grain to the bottom of the cage and keeping pups with a lactating female. As heterozygotes are indistinguishable phenotypically from wild type mice, they must be identified by a PCR based genotyping assay.
- Additional Breeding and Husbandry Support
Appearance
- black, ataxic, tremors
  Related Genotype: a/a Rora^sg/Rora^sg
  
  black, unaffected
  Related Genotype: a/a +/? or a/a Rora^sg/+
Citation
When using the B6-staggerer mouse strain in a publication, please cite the originating article(s) and include JAX stock #002651 in your Materials and Methods section.

Animal Health Reports

Facility Barrier Level Descriptions

Production of mice from cryopreserved embryos or sperm occurs in a maximum barrier room, G200

Pricing & Availability

Cryo Recovery

Domestic
International

Live Mouse

Age

Genotype

Price

weeks

Cryorecovery - Pricing

Service/Product	Description	Price
	Heterozygous or Wild-type for Rora<sg>

Payment Terms and Conditions

Terms are granted by individual review and stated on the customer invoice(s) and account statement. These transactions are payable in U.S. currency within the granted terms. Payment for services, products, shipping containers, and shipping costs that are rendered are expected within the payment terms indicated on the invoice or stated by contract. Invoices and account balances in arrears of stated terms may result in The Jackson Laboratory pursuing collection activities including but not limited to outside agencies and court filings.

The Jackson Laboratory's Genotype Promise

The Jackson Laboratory has rigorous genetic quality control and mutant gene genotyping programs to ensure the genetic background of JAX® Mice strains as well as the genotypes of strains with identified molecular mutations. JAX® Mice strains are only made available to researchers after meeting our standards. However, the phenotype of each strain may not be fully characterized and/or captured in the strain data sheets. Therefore, we cannot guarantee a strain's phenotype will meet all expectations. To ensure that JAX® Mice will meet the needs of individual research projects or when requesting a strain that is new to your research, we suggest ordering and performing tests on a small number of mice to determine suitability for your particular project. We do not guarantee breeding performance and therefore suggest that investigators order more than one breeding pair to avoid delays in their research.

Terms Of Use

General Terms and Conditions

Questions about Terms of Use

Licensing Information

Phone: 207-288-6470

Email: TechTran@jax.org

JAX® Mice, Products & Services Conditions of Use

"MICE" means mouse strains, their progeny derived by inbreeding or crossbreeding, unmodified derivatives from mouse strains or their progeny supplied by The Jackson Laboratory ("JACKSON"). "PRODUCT(S)" means biological materials supplied by JACKSON, and their derivatives. "SERVICES" means projects conducted by JACKSON for other parties that may include but are not limited to the use of MICE or PRODUCTS. "RECIPIENT" means each recipient of MICE, PRODUCTS, or SERVICES provided by JACKSON including each institution, its employees and other researchers under its control. MICE or PRODUCTS shall not be: (i) used for any purpose other than internal research, (ii) sold or otherwise provided to any third party for any use, or (iii) provided to any agent or other third party to provide breeding or other services. Acceptance of MICE, PRODUCTS or SERVICES from JACKSON shall be deemed as agreement by RECIPIENT to these conditions, and departure from these conditions requires JACKSON’s prior written authorization.

No Warranty

MICE, PRODUCTS AND SERVICES ARE PROVIDED "AS IS". JACKSON EXTENDS NO WARRANTIES OF ANY KIND, EITHER EXPRESS, IMPLIED, OR STATUTORY, WITH RESPECT TO MICE, PRODUCTS OR SERVICES, INCLUDING ANY IMPLIED WARRANTY OF MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE, OR ANY WARRANTY OF NON-INFRINGEMENT OF ANY PATENT, TRADEMARK, OR OTHER INTELLECTUAL PROPERTY RIGHTS.

Credit for PRODUCTS or SERVICES

In case of dissatisfaction for a valid reason and claimed in writing by a purchaser within ninety (90) days of receipt of, PRODUCTS or SERVICES, JACKSON will, at its option, provide credit or replacement for the PRODUCT received or the SERVICES provided; JACKSON makes no other representations and this shall be the exclusive remedy of the purchaser. Please note specific policy for live mice.

Animal Care and Use for SERVICES

Consistent with the requirement for a written understanding regarding animal care and use, the JACKSON Animal Care and Use Committee will review the animal care and use protocol(s) associated with any SERVICES to be performed at JACKSON, and JACKSON shall have ultimate responsibility and authority for the care of animals while on site or in JACKSON custody.

No Liability

In no event shall JACKSON, its trustees, directors, officers, employees, and affiliates be liable for any causes of action or damages, including any direct, indirect, special, or consequential damages, arising out of the provision of MICE, PRODUCTS, or SERVICES, including economic damage or injury to property and lost profits, and including any damage arising from acts or negligence on the part of JACKSON, its agents or employees. Unless prohibited by law, in purchasing or receiving MICE, PRODUCTS, or SERVICES from JACKSON, purchaser or recipient, or any party claiming by or through them, expressly releases and discharges JACKSON from all such causes of action or damages, and further agrees to defend and indemnify JACKSON from any costs or damages arising out of any third party claims.

MICE, PRODUCTS or SERVICES are to be used in a safe manner and in accordance with all applicable governmental rules and regulations.

The foregoing represents the General Terms and Conditions applicable to JACKSON’s MICE, PRODUCTS or SERVICES. In addition, special terms and conditions of sale of certain MICE, PRODUCTS, or SERVICES may be set forth separately in JACKSON web pages, catalogs, price lists, contracts, and/or other documents, and these special terms and conditions shall also govern the sale of these MICE, PRODUCTS and SERVICES by JACKSON, and by its licensees and distributors.

Acceptance of delivery of MICE, PRODUCTS or SERVICES shall be deemed agreement to these terms and conditions. No purchase order or other document transmitted by purchaser or recipient that may modify the terms and conditions hereof, shall be in any way binding on JACKSON, and instead the terms and conditions set forth herein, including any special terms and conditions set forth separately, shall govern the sale of MICE, PRODUCTS or SERVICES by JACKSON.

Also Known As:B6-staggerer

Genetic overview

Research Applications

Base Price

Detailed Description

Development

Control Suggestions

Additional Information

Selected References

Rorasg

Allele Symbol: Rorasg

Disease Terms

Research Areas By Phenotype

This mouse can be used to support research in many areas including:

Genotype: Rorasg related

Mammalian Phenotype Terms by Genotype

Genotype: Rorasg/Rorasginvolves: obese stock

behavior/neurological phenotype

growth/size/body region phenotype

homeostasis/metabolism phenotype

mortality/aging

nervous system phenotype

Genotype: Rorasg/Rorasginvolves: C57BL/6

behavior/neurological phenotype

endocrine/exocrine gland phenotype

hematopoietic system phenotype

homeostasis/metabolism phenotype

immune system phenotype

mammalian phenotype

muscle phenotype

nervous system phenotype

reproductive system phenotype

respiratory system phenotype

taste/olfaction phenotype

cardiovascular system phenotype

Genotype: Rorasg/Rorasginvolves: C57BL

cellular phenotype

homeostasis/metabolism phenotype

nervous system phenotype

Genotype: Rorasg/Rora+involves: C57BL

nervous system phenotype

Genotype: Rorasg/Rora+involves: C57BL/6J

behavior/neurological phenotype

References

Additional References

Additional - Rorasg related

Genotyping Protocols

Breeding Considerations

Appearance

Citation

Animal Health Reports

Production of mice from cryopreserved embryos or sperm occurs in a maximum barrier room, G200

Live Mouse

Cryorecovery - Pricing

Payment Terms and Conditions

The Jackson Laboratory's Genotype Promise

Terms Of Use

Licensing Information

JAX® Mice, Products & Services Conditions of Use

No Warranty

Credit for PRODUCTS or SERVICES

Animal Care and Use for SERVICES

No Liability

Rora^sg

Allele Symbol: Rora^sg

Genotype: Rora^sg related

Genotype: Rora^sg/Rora^sg
involves: obese stock

Genotype: Rora^sg/Rora^sg
involves: C57BL/6

Genotype: Rora^sg/Rora^sg
involves: C57BL

Genotype: Rora^sg/Rora⁺
involves: C57BL

Genotype: Rora^sg/Rora⁺
involves: C57BL/6J

Additional - Rora^sg related